Soluble plasma or serum proteins have previously been reported as capable of distinguishing HL from healthy patients through immune response-related markers such as PDL1, CCL17, CCL3, IL13, MMP12, TNFRS4, and LAG3 (13). This evidence concerns the gene CCL3 and Hodgkins lymphoma.